Case 1 History: A 53 year-old woman presented with a frontal-parietal lobe intra-axial tumor.

6
Diagnostic Challenge Pathology for Neurosurgery & Neurology Residents Department of Pathology University of Oklahoma Health Sciences Center, Oklahoma City, OK, U.S.A. Case 1 History: A 53 year-old woman presented with a frontal-parietal lobe intra-axial tumor. Contributor: Kar-Ming Fung, M.D., Ph.D., [email protected] Last updataded: 1/9/2009

description

Diagnostic Challenge Pathology for Neurosurgery & Neurology Residents Department of Pathology University of Oklahoma Health Sciences Center, Oklahoma City, OK, U.S.A. Case 1 History: A 53 year-old woman presented with a frontal-parietal lobe intra-axial tumor. - PowerPoint PPT Presentation

Transcript of Case 1 History: A 53 year-old woman presented with a frontal-parietal lobe intra-axial tumor.

Page 1: Case 1 History: A 53 year-old woman presented with a frontal-parietal lobe intra-axial tumor.

Diagnostic ChallengePathology for Neurosurgery & Neurology

ResidentsDepartment of Pathology

University of Oklahoma Health Sciences Center,Oklahoma City, OK, U.S.A.

Case 1History: A 53 year-old woman presented with a frontal-parietal lobe intra-axial tumor.

Contributor: Kar-Ming Fung, M.D., Ph.D., [email protected] Last updataded: 1/9/2009

Page 2: Case 1 History: A 53 year-old woman presented with a frontal-parietal lobe intra-axial tumor.

Cytologic PreparationFrozen Section

A B

Page 3: Case 1 History: A 53 year-old woman presented with a frontal-parietal lobe intra-axial tumor.

Paraffin Section Paraffin Section

C D

Page 4: Case 1 History: A 53 year-old woman presented with a frontal-parietal lobe intra-axial tumor.

Thyroid transcription factor-1 (TTF-1)

Gross cystic disease fluid protein-15 (GCDFP-15)

E F

Page 5: Case 1 History: A 53 year-old woman presented with a frontal-parietal lobe intra-axial tumor.

What is your diagnosis?

Page 6: Case 1 History: A 53 year-old woman presented with a frontal-parietal lobe intra-axial tumor.

Diagnosis: Metastatic adenocarcinoma of breast origin.Discussion: • The cells are highly pleomorphic with large nuclei

and nucleoli (Panel A and B). The cytologic features are best appreciated in the cytologic preparation (Panel B).

• The tumor cells form solid sheets. In between the tumor cells are small glands that contain mucin (arrow in the panel on the right).

• The glandular structure are well demonstrated in permanent sections (Panel C). There are also necrosis (Panel D).

• Putting all of these together, the features are most consistent with a metastatic adenocarcarcinoma.

• The patient has a history of breast carcinoma. The positive immunoreactivity of GCDFP-15 confirmed the breast origin. Breast carcinoma are usually negative for TTF-1.